The 12 closest competitors and alternatives to Enzymatica among health care companies — ranked by similarity to what Enzymatica actually does, not by market-cap band.
Subscribe to see Enzymatica’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Enzymatica develops health solutions and barrier technology products, such as the ColdZyme mouth spray, designed to support the body's defense against viruses and micro-organisms. The company serves consumers looking to prevent or alleviate common cold symptoms and respiratory infections.
Enzymatica is a health care company headquartered in Sweden. Xcout tracks 4 named people at Enzymatica, including Bengt Baron (Styrelseledamot).
Ranked by semantic similarity — how close each company is to Enzymatica by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Healthcare
Biograil ApS is a Copenhagen-based pre-clinical stage pharmaceutical and biotech company developing a unique oral device for the delivery of therapeutics. The company collaborates with major industry partners like CSL.
Biotech
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.
Biotechnology
Eterna Regeneratives develops regenerative biomaterials and protein-derived scaffolds designed for mineralisation and tissue regeneration. The company's initial applications focus on oral health and enamel repair through professional consumer dental care formats, as well as bone regeneration for orthopaedic and bone grafting uses.
Biotechnology
Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Pharmaceuticals
UPSA is a French pharmaceutical laboratory that manufactures and provides over-the-counter medications, medical devices, and dietary supplements to help patients treat common, everyday ailments. The company operates across six main therapeutic areas, including pain and fever, ENT, digestion, sleep, women's health, and vitality.
Biotechnology
Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.
Pharmaceuticals
The Klosterfrau Group is a German healthcare company that develops, produces, and distributes over-the-counter pharmaceuticals, consumer healthcare products, medical products, cosmetics, and contract manufacturing solutions. It serves consumers seeking health, wellness, and self-medication products across national and international markets.
Biotechnology
Eyenovia, Inc. is a New York-based ophthalmic technology and pharmaceutical manufacturing company focused on targeted drug-delivery solutions for eye care using its proprietary Optejet device.
Biotech
Ondine Biomedical Inc., a life sciences firm, specializes in the research, development, and commercialization of advanced antimicrobial photodisinfection therapies, operating both within Canada and internationally. Its foundational technology is Photodisinfection, a state-of-the-art, light-based topical antimicrobial approach designed to neutralize detrimental pathogens. The company's flagship product, Steriwave, is a medical device leveraging photodisinfection to eradicate harmful nasal pathogens, thereby significantly mitigating healthcare-acquired infections. Furthermore, Ondine Biomedical's development pipeline includes a topical antiviral treatment for the upper respiratory tract aimed at reducing SARS-CoV-2 viral load and transmission; a solution for addressing chronic rhinosinusitis; OND1002, an agent for disinfecting endotracheal tubes to decrease the occurrence of ventilator-associated pneumonia; and OND1003, formulated for the decolonization of burns and wounds. Established in 1996, the company maintains its corporate headquarters in Vancouver, Canada.
Life Science
Amferia is a Swedish biotechnology company specializing in antimicrobial wound-care solutions using bio-inspired peptides. Founded in Gothenburg, the company operates a clinical production site in Mölndal for testing and evaluating its healthcare products.
Similar health care company
Enorama Pharma is a Swedish pharmaceutical company that develops and commercializes consumer-friendly oral nicotine products, specifically focusing on tobacco-free white snus. The company markets its products under its proprietary NIC-S brand and through private labels, with a primary focus on the U.S. market.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Enzymaticaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →